Device Trial Radar · NCT06229470
Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pain
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
250
Actual
Start
Mar 8, 2024
Primary completion
Feb 28, 2027
Study completion Feb 28, 2027
Sponsor
- Lead sponsor
- Saluda Medical Pty LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 29, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the clinical utility of neurophysiological measurements of ECAP-controlled closed-loop SCS (i.e., neural panel metrics) to guide treatment of chronic pain of the trunk and/or limbs.
Conditions
- Chronic Pain
Interventions
Evoke Spinal Cord Stimulation (SCS) SystemDevice
A spinal cord stimulation (SCS) system that measures and records evoked compound action potentials (ECAPs) and automatically adjusts the stimulation current to maintain a consistent ECAP amplitude.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Evoked Compound Action Potentials (ECAPs) as measured by the Evoke SCS SystemTime frame: through 6-months post-implant
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Lakeside Spine and Pain
Lake Havasu City, Arizona
Spanish Hills Interventional Pain Specialists
Camarillo, California
Pain Consultants of San Diego
La Mesa, California
22 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.